Phase 1 trial starts for HCV protease inhibitor.
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D011480:Protease Inhibitors